Parkwalk Advisors is a London-based venture capital firm and the UK's most active investor in university spinouts. It bridges the funding gap between early academic discovery and later-stage venture capital, backing deeptech, healthtech, and cleantech companies emerging from UK universities and research institutions.
Deal activity increased 80% year-over-year (9 deals in the last 12 months). Average disclosed round size is $23.0M (across 56 rounds with reported amounts).
Portfolio
87
Fund Size
—
Top Stage
Series A
Last 12 Mo
9
Team
David Townsend
Managing Director, IP Capital
Joyce Xie
Managing Director, Global Capital, Institutional Fundraising
Greg Smith
Director, IP Group CEO
George Van Horn
Vice President, IP Capital
Danielle Acuy
Senior Business & Data Analyst
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Quantum Motion | Series B | — | May 2026 |
 Semarion | Seed | $3.8M | Mar 2026 |
 Brainomix | Series C | $25.4M | Feb 2026 |
 xWatts | Seed | — | Feb 2026 |
 Densix | Seed | $4M | Jan 2026 |
 Quantum Motion | Series C | $160M | Jan 2026 |
 Fluidic | Series A | $31M | Jan 2026 |
 Scripta | Seed | $12M | Nov 2025 |
 CamGene Therapeutics | Seed | — | Nov 2025 |
 Trismik | Pre-Seed | — | Sep 2025 |
| EEnhanced Genomics | Series A | — | Sep 2025 |
 Phasecraft | Series B | — | Sep 2025 |
 Paragraf | Series C | $55M | Aug 2025 |
 Bitfount | Series A | — | Jul 2025 |
| Brainomix | Series C | $18M | Mar 2025 |
 Cambridge GaN Devices | Series C | — | Feb 2025 |
| Trismik | Pre-Seed | — | Jan 2025 |
| Paragraf | Series C | — | Jan 2025 |
 mintneuro | Unknown | — | Nov 2024 |
| OOW Smell Made Digital | Seed | $2.8M | Aug 2024 |
 Oxford Endovascular | Series A | — | May 2024 |
 Echopoint Medical | Series A | — | Jan 2024 |
| Phasecraft | Series A | — | Aug 2023 |
 Legislate | Seed | $3.6M | Mar 2023 |
| Quantum Motion | Growth | $51M | Feb 2023 |
Top Co-Investors
Last updated: 7 October 2026